PUBLIC RESEARCH DOSSIER
INBX · Nasdaq英希布里克斯生物科学
Manufacturing · Biological Products, (No Diagnostic Substances)完成交易日收盘US$80.28-7.47%行情日期 2026-11-05 · 非实时
公开资料页汇总英希布里克斯生物科学（INBX）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-05，非实时；缺失值不按零处理。
股价走势
复权收盘价（美元）
2025-11-04 — 2026-11-05253 个交易日样本
INBXUS$80.28
查看图表数据
| 日期 | INBX |
|---|---|
| 2025-11-04 | 81.99 |
| 2025-11-05 | 82.27 |
| 2025-11-06 | 80.99 |
| 2025-11-07 | 80.69 |
| 2025-11-10 | 79 |
| 2025-11-11 | 77.84 |
| 2025-11-12 | 73.32 |
| 2025-11-13 | 74.62 |
| 2025-11-14 | 79.13 |
| 2025-11-17 | 77.35 |
| 2025-11-18 | 77.59 |
| 2025-11-19 | 82.14 |
| 2025-11-20 | 79.84 |
| 2025-11-21 | 83.93 |
| 2025-11-24 | 81.01 |
| 2025-11-25 | 82.68 |
| 2025-11-26 | 83.66 |
| 2025-11-28 | 84.12 |
| 2025-12-01 | 80.77 |
| 2025-12-02 | 82.25 |
| 2025-12-03 | 82.96 |
| 2025-12-04 | 87.41 |
| 2025-12-05 | 89.47 |
| 2025-12-08 | 93.51 |
| 2025-12-09 | 88.89 |
| 2025-12-10 | 84.51 |
| 2025-12-11 | 82.21 |
| 2025-12-12 | 79.57 |
| 2025-12-15 | 76.21 |
| 2025-12-16 | 81.57 |
| 2025-12-17 | 83.09 |
| 2025-12-18 | 85.32 |
| 2025-12-19 | 86.13 |
| 2025-12-22 | 87.52 |
| 2025-12-23 | 78.08 |
| 2025-12-24 | 80.36 |
| 2025-12-26 | 80.21 |
| 2025-12-29 | 79.27 |
| 2025-12-30 | 77.98 |
| 2025-12-31 | 79 |
| 2026-01-02 | 75.04 |
| 2026-01-05 | 76.88 |
| 2026-01-06 | 76.1 |
| 2026-01-07 | 75.93 |
| 2026-01-08 | 75.2 |
| 2026-01-09 | 72.86 |
| 2026-01-12 | 75.94 |
| 2026-01-13 | 73.28 |
| 2026-01-14 | 75.93 |
| 2026-01-15 | 71.8 |
| 2026-01-16 | 72.27 |
| 2026-01-20 | 72.9 |
| 2026-01-21 | 75.1 |
| 2026-01-22 | 79.49 |
| 2026-01-23 | 74.66 |
| 2026-01-26 | 72 |
| 2026-01-27 | 73.49 |
| 2026-01-28 | 73.98 |
| 2026-01-29 | 72.56 |
| 2026-01-30 | 76.27 |
| 2026-02-02 | 82.23 |
| 2026-02-03 | 85.08 |
| 2026-02-04 | 82.56 |
| 2026-02-05 | 81.53 |
| 2026-02-06 | 83.91 |
| 2026-02-09 | 86.49 |
| 2026-02-10 | 83.3 |
| 2026-02-11 | 81.99 |
| 2026-02-12 | 82.11 |
| 2026-02-13 | 75.8 |
| 2026-02-17 | 78.77 |
| 2026-02-18 | 81.58 |
| 2026-02-19 | 81.08 |
| 2026-02-20 | 78.64 |
| 2026-02-23 | 76.59 |
| 2026-02-24 | 79.5 |
| 2026-02-25 | 80.27 |
| 2026-02-26 | 77.23 |
| 2026-02-27 | 74.13 |
| 2026-03-02 | 77.49 |
| 2026-03-03 | 74.33 |
| 2026-03-04 | 74.63 |
| 2026-03-05 | 70.66 |
| 2026-03-06 | 69.18 |
| 2026-03-09 | 71.86 |
| 2026-03-10 | 71.63 |
| 2026-03-11 | 73.5 |
| 2026-03-12 | 69.3 |
| 2026-03-13 | 68.74 |
| 2026-03-16 | 69.26 |
| 2026-03-17 | 69.71 |
| 2026-03-18 | 68.69 |
| 2026-03-19 | 64.87 |
| 2026-03-20 | 60.92 |
| 2026-03-23 | 64.63 |
| 2026-03-24 | 63.12 |
| 2026-03-25 | 66.46 |
| 2026-03-26 | 65.79 |
| 2026-03-27 | 58.39 |
| 2026-03-30 | 59.88 |
| 2026-03-31 | 67.23 |
| 2026-04-01 | 67.05 |
| 2026-04-02 | 63.53 |
| 2026-04-06 | 63.72 |
| 2026-04-07 | 62.35 |
| 2026-04-08 | 67.13 |
| 2026-04-09 | 75.75 |
| 2026-04-10 | 75.27 |
| 2026-04-13 | 77.46 |
| 2026-04-14 | 83.19 |
| 2026-04-15 | 83.6 |
| 2026-04-16 | 83.11 |
| 2026-04-17 | 88.23 |
| 2026-04-20 | 82.39 |
| 2026-04-21 | 84.08 |
| 2026-04-22 | 115.09 |
| 2026-04-23 | 119.93 |
| 2026-04-24 | 129.06 |
| 2026-04-27 | 131.45 |
| 2026-04-28 | 130.67 |
| 2026-04-29 | 124.82 |
| 2026-04-30 | 129.21 |
| 2026-05-01 | 128.79 |
| 2026-05-04 | 127.95 |
| 2026-05-05 | 128.12 |
| 2026-05-06 | 141.84 |
| 2026-05-07 | 124.52 |
| 2026-05-08 | 134.35 |
| 2026-05-11 | 127.58 |
| 2026-05-12 | 108.65 |
| 2026-05-13 | 117.95 |
| 2026-05-14 | 116.16 |
| 2026-05-15 | 108.64 |
| 2026-05-18 | 105.8 |
| 2026-05-19 | 109.51 |
| 2026-05-20 | 110.01 |
| 2026-05-21 | 110.57 |
| 2026-05-22 | 101.32 |
| 2026-05-26 | 106.85 |
| 2026-05-27 | 103 |
| 2026-05-28 | 103.98 |
| 2026-05-29 | 104.01 |
| 2026-06-01 | 99.29 |
| 2026-06-02 | 93.63 |
| 2026-06-03 | 95.22 |
| 2026-06-04 | 91.25 |
| 2026-06-05 | 87.01 |
| 2026-06-08 | 89.13 |
| 2026-06-09 | 89.1 |
| 2026-06-10 | 89.47 |
| 2026-06-11 | 93.54 |
| 2026-06-12 | 92.2 |
| 2026-06-15 | 93.51 |
| 2026-06-16 | 93.11 |
| 2026-06-17 | 94.2 |
| 2026-06-18 | 93.05 |
| 2026-06-22 | 93.3 |
| 2026-06-23 | 92.91 |
| 2026-06-24 | 95.14 |
| 2026-06-25 | 95.31 |
| 2026-06-26 | 94.81 |
| 2026-06-29 | 95.5 |
| 2026-06-30 | 94.75 |
| 2026-07-01 | 94.94 |
| 2026-07-02 | 97.58 |
| 2026-07-06 | 97.14 |
| 2026-07-07 | 100.75 |
| 2026-07-08 | 97.1 |
| 2026-07-09 | 103.85 |
| 2026-07-10 | 93.01 |
| 2026-07-13 | 92.17 |
| 2026-07-14 | 93.21 |
| 2026-07-15 | 91.22 |
| 2026-07-16 | 89.07 |
| 2026-07-17 | 87.39 |
| 2026-07-20 | 84.09 |
| 2026-07-21 | 87.61 |
| 2026-07-22 | 85.92 |
| 2026-07-23 | 85 |
| 2026-07-24 | 81.55 |
| 2026-07-27 | 82.45 |
| 2026-07-28 | 79.68 |
| 2026-07-29 | 79.25 |
| 2026-07-30 | 84.73 |
| 2026-07-31 | 82.05 |
| 2026-08-03 | 82.72 |
| 2026-08-04 | 83.53 |
| 2026-08-05 | 83.89 |
| 2026-08-06 | 85.79 |
| 2026-08-07 | 88.66 |
| 2026-08-10 | 93.11 |
| 2026-08-11 | 92.38 |
| 2026-08-12 | 98.36 |
| 2026-08-13 | 97.01 |
| 2026-08-14 | 88.37 |
| 2026-08-17 | 92.01 |
| 2026-08-18 | 94.62 |
| 2026-08-19 | 101.48 |
| 2026-08-20 | 99.15 |
| 2026-08-21 | 103.63 |
| 2026-08-24 | 104.94 |
| 2026-08-25 | 122.72 |
| 2026-08-26 | 125.34 |
| 2026-08-27 | 123.93 |
| 2026-08-28 | 123.41 |
| 2026-08-31 | 126.7 |
| 2026-09-01 | 124.66 |
| 2026-09-02 | 124.97 |
| 2026-09-03 | 122.26 |
| 2026-09-04 | 121.17 |
| 2026-09-08 | 114.34 |
| 2026-09-09 | 112.86 |
| 2026-09-10 | 111.42 |
| 2026-09-11 | 109.27 |
| 2026-09-14 | 110.47 |
| 2026-09-15 | 105.61 |
| 2026-09-16 | 101.77 |
| 2026-09-17 | 104.73 |
| 2026-09-18 | 109.35 |
| 2026-09-21 | 112.04 |
| 2026-09-22 | 110.67 |
| 2026-09-23 | 100.33 |
| 2026-09-24 | 100.4 |
| 2026-09-25 | 99.61 |
| 2026-09-28 | 101.71 |
| 2026-09-29 | 104.83 |
| 2026-09-30 | 100.08 |
| 2026-10-01 | 97.93 |
| 2026-10-02 | 96.99 |
| 2026-10-05 | 94.56 |
| 2026-10-06 | 93.41 |
| 2026-10-07 | 93.36 |
| 2026-10-08 | 92.76 |
| 2026-10-09 | 95.01 |
| 2026-10-12 | 90.53 |
| 2026-10-13 | 87.08 |
| 2026-10-14 | 85.26 |
| 2026-10-15 | 90.5 |
| 2026-10-16 | 89.83 |
| 2026-10-19 | 89.79 |
| 2026-10-20 | 95.3 |
| 2026-10-21 | 98.19 |
| 2026-10-22 | 97.1 |
| 2026-10-23 | 93.38 |
| 2026-10-26 | 88.61 |
| 2026-10-27 | 95.66 |
| 2026-10-28 | 73.29 |
| 2026-10-29 | 73.65 |
| 2026-10-30 | 71.78 |
| 2026-11-02 | 72.16 |
| 2026-11-03 | 81.08 |
| 2026-11-04 | 86.76 |
| 2026-11-05 | 80.28 |
1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。
使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。
01 · MARKET FRAME
行情、估值与风险
基于已完成交易日和已发布财务资料
区间涨跌幅
区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。
02 · FINANCIAL TRACE
财务摘要
公开页仅显示最近3个已校验报告期
年度财务走势
百万美元 · 年度报告期
营收1.3百万美元
| 指标 | 2026-08-07 | 2026-06-30 | 2025-12-31 | 2025-08-08 | 2025-06-30 | 2024-12-31 | 2024-08-09 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| 营收 | — | — | 1.3 | — | — | 0.2 | — | — | 1.8 |
| 净利润 | — | — | -140.1 | — | — | 1,687.6 | — | — | -241.4 |
| 自由现金流 | — | — | -129.8 | — | — | -197 | — | — | -197.9 |
| 股份数 | 14.7 | — | — | 14.5 | — | — | 14.5 | — | — |
| 债务 | — | — | — | — | — | — | — | — | — |
| 总资产 | — | 154.2 | — | — | 212.1 | — | — | 258.4 | — |
报告营收口径
金额及股份数均以百万为单位。缺失或待核验数据不按零处理。
03 · PEER SET
同业对比
同一细分行业中市值最接近的公司
| 公司 | 市值 | 近250日涨跌幅 | 市盈率 | 距52周高点 | 波动率 |
|---|---|---|---|---|---|
| VORVor生物制药 | US$1.1B | -1.6% | 1.8× | -25.7% | +105% |
| IMCR免疫核心 | US$1.5B | -10.1% | — | -29.4% | +37% |
| NVAX诺瓦瓦克斯医药 | US$1.6B | +28.9% | — | -23.7% | +71.7% |
| MAZEMaze治疗 | US$1.8B | +9.8% | — | -37.2% | +67.5% |
同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。